Tocqueville Asset Management’s Immunomedics Inc IMMU Stock Holding History

Tocqueville Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-35,000	Closed	-$472K	–	693
2020 Q1	$472K	Hold	35,000	–	–	0.01%	465
2019 Q4	$741K	Sell	35,000 -16,300	-32%	-$288K	0.01%	491
2019 Q3	$680K	Buy	51,300 +15,400	+43%	+$226K	0.01%	508
2019 Q2	$498K	Sell	35,900 -1,500	-4%	-$22.6K	0.01%	597
2019 Q1	$718K	Sell	37,400 -2,725	-7%	-$43.9K	0.01%	528
2018 Q4	$573K	Sell	40,125 -10,700	-21%	-$212K	0.01%	537
2018 Q3	$1.06M	Buy	50,825 +7,100	+16%	+$168K	0.01%	493
2018 Q2	$1.03M	Buy	43,725 +6,000	+16%	+$121K	0.01%	504
2018 Q1	$551K	Hold	37,725	–	–	0.01%	596
2017 Q4	$610K	Buy	+37,725	New	+$445K	0.01%	584

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Tocqueville Asset Management's IMMU Position: Q2 2020 in Review

Tocqueville Asset Management sold out of Immunomedics Inc (IMMU) in Q2 2020, closing a stake of 35,000 shares — an estimated $472K sold.

Tocqueville Asset Management first reported a position in IMMU in Q4 2017 and held it in 10 quarters. The position peaked at $1.06M in Q3 2018. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

Tocqueville Asset Management reported no remaining Immunomedics Inc position as of Q2 2020 after selling out during the quarter.
Tocqueville Asset Management sold 35,000 Immunomedics Inc shares in Q2 2020, an estimated $472K.
Tocqueville Asset Management first reported a position in Immunomedics Inc in Q4 2017 and held it in 10 quarters.
Tocqueville Asset Management's Immunomedics Inc position peaked at $1.06M in Q3 2018.
313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Tocqueville Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.